IPO

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Teamsters at a Wyomissing dispensary walk out, sparking a new labor battle with cannabis giant Cresco Labs over wages and stable hours.

Titan International beat expectations in Q4, driven by a 21% surge in its construction division, and now eyes a strong 2026 as OEM destocking ends.

Riding a wave of record profits and market optimism, the Florida insurer prepares to lay out its future strategy to top institutional investors.

Vista Gold Corp. launches a major public offering to advance its massive Mt. Todd gold project in Australia, testing investor appetite for junior miners.

DelphX Capital Markets raises fresh capital for its innovative structured notes, navigating weak financials and a competitive market for hybrid securities.

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

FTAI Aviation reports a massive profit turnaround and raises its dividend, signaling confidence. But a pivot to power generation may be the real story.

The water midstream leader's inaugural dividend signals financial confidence, but a look at its balance sheet reveals a complex picture of growth and debt.

Fintech giant Chime forecasts its first full year of GAAP profitability in 2026, propelled by its new ChimeCore platform, AI, and strong product growth.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

With record revenue and key battery tech milestones met, Enovix is on the brink of powering smartphones, but manufacturing hurdles and cash burn remain.

With $125 million in hand, ClearThink 1 enters a recovering SPAC market, setting its sights on a transformative deal in the dynamic financial services sector.

From a Bitcoin Runes asset to a decentralized AI network, Crypto Burger's new direction aims to unlock Bitcoin's programmable future after its Gate.io listing.

Eton Pharmaceuticals wins landmark FDA approval for DESMODA, a breakthrough liquid drug set to transform care for a rare condition by enabling precise, safe dosing.

A private market index tracking tech giants like SpaceX surged nearly 200% in 14 months, raising questions about a new, exclusive tier of wealth creation.

Struggling biotech Jupiter Neurosciences presents its Parkinson's drug to elite investors at Mar-a-Lago, betting its hybrid business model can win funding.

Amid a volatile market, Rock Tech Lithium's latest funding from existing investors signals strong confidence in its strategy to build a local battery supply chain.

With new CFO and Exploration SVP, Goldsky Resources signals a major push to develop its newly consolidated Swedish and Finnish gold and cobalt assets.